Corporate Information

Historic Stock Lookup Press Releases Stock Information Events Calendar Annual and Financial Reports Corporate GovernanceCorporate InformationCode of Business Conduct and EthicsAudit Committee CharterCompensation Committee CharterNominating and Corporate Governance Committee Charter Investor Contacts
  

Neurobiological Technologies, Inc. (Nasdaq: NTII)

2000 Powell Street, Suite 800
Emeryville, CA 94608
Tel. (510) 595-6000
Fax (510) 595-6006
www.ntii.com

State of Incorporation: Delaware

Fiscal Year End: June 30

Executive Team:
  • Paul E. Freiman, President and Chief Executive Officer
  • Lisa U. Carr, M.D., Ph.D., Senior Vice President, Chief Medical Officer
  • David E. Levy, M.D., Vice President of Clinical Development
  • Karl G. Trass, Vice President, Regulatory Affairs & Quality Assurance

Board of Directors:
  • Abraham E. Cohen, Chairman
  • Paul E. Freiman
  • Enoch Callaway, M.D.
  • Ronald E. Cape, Ph.D.
  • Theodore L. Eliot, Jr.
  • F. Van Kasper
  • Abraham D. Sofaer
  • John B. Stuppin

Audit Committee:
  • F. Van Kasper, Chairman
  • Theodore L. Eliot, Jr.
  • Abraham D. Sofaer

Compensation Committee
  • Abraham D. Sofaer, Chairman
  • Ronald E. Cape, Ph.D.
  • Theodore L. Eliot, Jr.

Nominating and Corporate Governance Committee:
  • Ronald E. Cape, Ph.D., Chairman
  • Enoch Callaway, M.D.
  • Abraham D. Sofaer